Alpha-1-antichymotrypsin (ACT or SERPINA3) polymorphism may affect age-at-onset and disease duration of Alzheimer’s disease - Kamboh, M I; Minster, R L; Kenney, M (Neurobiol Aging, 2006)
et al.